| Literature DB >> 445505 |
W T Creasman, S A Gall, J A Blessing, H J Schmidt, S Abu-Ghazaleh, J K Whisnant, P J DiSaia.
Abstract
The effectiveness of chemoimmunotherapy was evaluated in 45 previously untreated stage III ovarian cancer patients. Response rate, progression-free interval, and survival were considerably better than in a similar group of 63 patients treated with a single alkylating agent alone.Entities:
Mesh：
Substances：
Year: 1979 PMID： 445505
Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960